Evidence map

ReviewPharmaceuticals (Basel, Switzerland)2024

Therapeutic Potential of Targeting the PERK Signaling Pathway in Ischemic Stroke.

Xinyuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38543139